Immune Checkpoint Inhibitor-Induced Ptosis in a Patient With Prostate Cancer

J Neuroophthalmol. 2021 Mar 1;41(1):e71-e72. doi: 10.1097/WNO.0000000000000927.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adenocarcinoma / drug therapy*
  • Aged
  • Blepharoptosis / chemically induced*
  • Drug Therapy, Combination / adverse effects
  • Humans
  • Immune Checkpoint Inhibitors / adverse effects*
  • Immune Checkpoint Inhibitors / therapeutic use
  • Ipilimumab / adverse effects*
  • Ipilimumab / therapeutic use
  • Male
  • Nivolumab / adverse effects*
  • Nivolumab / therapeutic use
  • Prostatic Neoplasms / drug therapy*

Substances

  • Immune Checkpoint Inhibitors
  • Ipilimumab
  • Nivolumab